Vaginal microbicides and the prevention of HIV transmission
- 30 November 2008
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 8 (11), 685-697
- https://doi.org/10.1016/s1473-3099(08)70254-8
Abstract
No abstract availableKeywords
This publication has 156 references indexed in Scilit:
- Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2008
- Human Immunodeficiency Virus Type 1 (HIV-1) Integration: a Potential Target for Microbicides To Prevent Cell-Free or Cell-Associated HIV-1 InfectionAntimicrobial Agents and Chemotherapy, 2008
- Safety Trial of the Vaginal Microbicide Cellulose Sulfate Gel in HIV-Positive MenSexually Transmitted Diseases, 2007
- Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1Immunity, 2007
- Microbicides: A new frontier in HIV preventionBiologicals, 2006
- Cellulose Acetate 1,2-Benzenedicarboxylate Inhibits Infection by Cell-Free and Cell-Associated Primary HIV-1 IsolatesAIDS Research and Human Retroviruses, 2006
- Phase I safety study of Praneem polyherbal vaginal tablet use among HIV-uninfected women in Pune, IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- A Preponderance of CCR5+CXCR4+Mononuclear Cells Enhances Gastrointestinal Mucosal Susceptibility to Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2001
- Complexity and the Hawthorne Effect in Community TrialsEpidemiology, 1999
- Design of a “Microbicide” for Prevention of Sexually Transmitted Diseases Using “Inactive” Pharmaceutical ExcipientsBiologicals, 1999